Pre-Clinical Formulation Development

NSF Pharmalytica offers a full range of pre-clinical formulation development options. Formulation vehicles are evaluated and selected based on internal guidance documents, external sources and our staff's many years of experience. A variety of formulation options are available that have the potential to increase bioavailability across species for both hydrophobic and hydrophilic compounds.

In addition to the standard array of formulation vehicles, we also have a great deal of experience with cyclodextrins, phospholipids, injectable emulsions, self-emulsifying drug distribution systems (SEDDS), reverse micellar and solid solutions.

NSF Pharmalytica also has the capability to prepare even your most complex dose formulations, including sterile injectables, and to ship them to your toxicology CRO for dosing.